TY - JOUR
T1 - Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells
AU - Kadara, Humam
AU - Lacroix, Ludovic
AU - Lotan, Dafna
AU - Lotan, Reuben
N1 - Funding Information:
We thank Kenneth Dunner, Jr. for the elec‑ N‑(4‑hydroxyphenyl)retinamide (4HPR), also known as fenretinide, is a synthetic tron microscopy and Wendy Schober for retinoid, which has demonstrated low degree of toxicity relative to other retinoids, and assistance with flow cytometry. This study was has shown efficacy as chemopreventive and therapeutic agent in experimental models supported in part by Head and Neck Cancer and clinical trials.1‑3 For example, 4HPR was effective in clinical trials aimed at chemo‑ SPORE grant P50 CA97007 and the Cancer prevention of oral leukoplakias recurrence and new incidence in post surgical patients4 as Center Support Grant CA 16670 from the well as patients resistant to natural retinoids.5The proposed mechanism for these effects National Cancer Institute. was induction of apoptosis based largely on earlier studies, which have shown that 4HPR can induce apoptosis in a variety of cell lines including head and neck squamous cell carcinoma cells.6‑9 Several mechanisms have been proposed for the induction of apoptosis by 4HPR in different tumor cell types including ceramide induction,10 activation of nuclear retinoid receptors,8,11,12 triggering of the mitochondrial pathway and modulating mitochondrial membrane permeability,13‑15 cytochrome c release,13,15,16 activation of lipoxygenase 12,17 and activation of Jun N‑terminal kinase (JNK) and other mitogen‑ activated protein kinases (MAPKs).9,18‑20 Moreover, it has been previously shown that increase in ROS is an important and common feature of apoptosis by 4HPR in several cell lines.8,16,21,22
PY - 2007/1/1
Y1 - 2007/1/1
N2 - N-(4-hydroxyphenyl)retinamide (4HPR), which has shown efficacy in cancer chemoprevention and therapy, induces the mitochondrial apoptosis pathway via increased generation of reactive oxygen species (ROS). ROS is also known to be able to induce an endoplasmic reticulum (ER) stress response, which can contribute to apoptosis but may also antagonize it. Therefore, we used human head and neck squamous cell carcinoma (HNSCC) cells to determine whether 4HPR affects ER stress. Different experimental approaches have indicated that 4HPR induces ER stress response: electron microscopy, which showed extensive ER dilation; splicing of the X-box binding protein 1 (XBP-1), a marker of unfolded protein response (UPR) activation; and quantitative real-time PCR and immunoblotting, which revealed the up-regulation of several ER-stress associated mRNAs and proteins, including the chaperone heat shock protein HSPA1A. Most of these effects of 4HPR were abrogated by cotreatment of cells with the antioxidant 3-tert-butyl-4-hydroxyanisole (BHA) indicating that they were downstream of the increase in ROS. Furthermore, siRNA-mediated silencing and chemical inhibition of HSPA1A, which exerts either pro- or anti-apoptotic effects, decreased 4HPR-induced apoptosis. These results demonstrate that 4HPR induces ER stress and uncovered a pro-apoptotic role for HSPA1A in 4HPR-induced apoptosis.
AB - N-(4-hydroxyphenyl)retinamide (4HPR), which has shown efficacy in cancer chemoprevention and therapy, induces the mitochondrial apoptosis pathway via increased generation of reactive oxygen species (ROS). ROS is also known to be able to induce an endoplasmic reticulum (ER) stress response, which can contribute to apoptosis but may also antagonize it. Therefore, we used human head and neck squamous cell carcinoma (HNSCC) cells to determine whether 4HPR affects ER stress. Different experimental approaches have indicated that 4HPR induces ER stress response: electron microscopy, which showed extensive ER dilation; splicing of the X-box binding protein 1 (XBP-1), a marker of unfolded protein response (UPR) activation; and quantitative real-time PCR and immunoblotting, which revealed the up-regulation of several ER-stress associated mRNAs and proteins, including the chaperone heat shock protein HSPA1A. Most of these effects of 4HPR were abrogated by cotreatment of cells with the antioxidant 3-tert-butyl-4-hydroxyanisole (BHA) indicating that they were downstream of the increase in ROS. Furthermore, siRNA-mediated silencing and chemical inhibition of HSPA1A, which exerts either pro- or anti-apoptotic effects, decreased 4HPR-induced apoptosis. These results demonstrate that 4HPR induces ER stress and uncovered a pro-apoptotic role for HSPA1A in 4HPR-induced apoptosis.
KW - 4HPR
KW - Apoptosis
KW - ER stress
KW - HNSCC
KW - Reactive oxygen species
UR - http://www.scopus.com/inward/record.url?scp=34548292913&partnerID=8YFLogxK
U2 - 10.4161/cbt.6.5.3963
DO - 10.4161/cbt.6.5.3963
M3 - Article
C2 - 17404501
AN - SCOPUS:34548292913
SN - 1538-4047
VL - 6
SP - 705
EP - 711
JO - Cancer Biology and Therapy
JF - Cancer Biology and Therapy
IS - 5
ER -